Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Cue Health Inc. (HLTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement, by and between Cue Health Inc. and Cowen and Company, LLC",
"Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation"
08/09/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Cue Health Reports Second Quarter 2023 Financial Results"
08/07/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/03/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes"
07/31/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
06/09/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/07/2023 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
06/06/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test Cue’s COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company’s innovative test-to-treatment platform"
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 ARS Form ARS - Annual Report to Security Holders:
03/20/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test"
03/16/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/15/2023 8-K Quarterly results
Docs: "Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT"
03/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2023 SC 13G/A Khattak Ayub K reports a 7.6% stake in CUE HEALTH INC.
02/14/2023 SC 13G/A OAKMONT Corp reports a 6.4% stake in CUE HEALTH INC.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/05/2023 8-K Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits  Interactive Data
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
10/11/2022 8-K Appointed a new director
09/27/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/10/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
08/09/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/22/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy